Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Novel biomarker for ankylosing spondylitis identified

Nov. 22, 2011

New antiarrhythmic agent demonstrates good efficacy and safety in pilot study

Nov. 21, 2011

New VPAC2 receptor agonist demonstrates antihypertensive potential

Nov. 21, 2011

Pan-tyrosine-protein kinase inhibitor shows potential for treatment of multiple sclerosis

Nov. 21, 2011

Early clinical studies of CTP-499 conducted in healthy subjects

Nov. 21, 2011

Phase III study of canakinumab in systemic juvenile idiopathic arthritis completed

Nov. 21, 2011

Phase II data reported for S*BIO's SB-939

Nov. 21, 2011

Promising preclinical results presented for LDK-378

Nov. 18, 2011

Protein linked to prognosis of adenocarcinomas of the lung

Nov. 18, 2011

EZN-3042 administered with docetaxel in phase I study

Nov. 18, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...